Cover Image
市場調查報告書

歐洲的持續血糖檢測監測 (CGM) 市場

European Market Report for Continuous Glucose Monitoring 2016 - MedCore

出版商 iData Research Inc. 商品編碼 370720
出版日期 內容資訊 英文 77 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
歐洲的持續血糖檢測監測 (CGM) 市場 European Market Report for Continuous Glucose Monitoring 2016 - MedCore
出版日期: 2016年09月01日 內容資訊: 英文 77 Pages
簡介

本報告提供歐洲的持續血糖檢測監測 (CGM) 市場相關調查分析,市場概要,市場分析與預測,推動因素、阻礙因素,競爭分析等系統性資訊。

第1章 調查手法

第2章 疾病概要

  • 簡介
    • 糖尿病的種類
    • 糖尿病的併發症
    • 第一型、第二型糖尿病相關的危險因素
    • 徵兆與症狀
    • 糖尿病監測
    • 治療
    • 藥物遞輸系統

第3章 國家概況

  • 簡介
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 荷比盧三國
  • 北歐各國
  • 奧地利
  • 瑞士
  • 葡萄牙

第4章 持續血糖檢測監測 (CGM) 市場

  • 簡介
  • 市場分析與預測
  • 推動因素、阻礙因素
    • 推動市場要素
    • 市場阻礙因素
  • 競爭市場佔有率分析

簡稱

目錄
Product Code: iDATA_EUDD16_MC_CGM

The European CGM market comprises the CGM system segment and the CGM sensor segment. The business model for CGM is similar to traditional blood glucose meters, where the CGM system is the base equipment and the majority of sales are made from the disposable sensor component, which is replaced every three to seven days depending on the manufacturer. The CGM market is still considered to be in its infancy, but the disposable sensors will be the most important revenue generator as the technology gains further acceptance.

Continuous glucose monitoring (CGM) allows for a more accurate reading of how blood glucose levels fluctuate throughout the day by measuring interstitial glucose levels on a continuous basis and estimating blood glucose levels based on these readings.

The CGM system is typically made up of three components: a glucose sensor, transmitter and receiver. The sensor is inserted under the skin into the interstitial fluid and held with an adhesive. Sensors are typically sold in groups of four and are labeled for three to seven days of use, depending on the manufacturer. A transmitter takes the glucose reading from the sensor and wirelessly sends it to a small, hand-held receiver. If glucose levels are too low or high, the receiver warns the patient. Some manufacturers have even built-in a threshold audible alarm as a fixed safety feature when the patient approaches levels below 55 mg/dL, at which point the patient is still interactive but severely hypoglycemic.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

EUROPEAN MARKET FOR DIABETES MONITORING, TREATMENT AND DRUG DELIVERY

COMPETITIVE ANALYSIS

MARKET TRENDS

MARKET DEVELOPMENTS

MARKETS INCLUDED

KEY REPORT UPDATES

VERSION HISTORY

RESEARCH METHODOLOGY

  • 1.1 RESEARCH SCOPE
  • 1.2 IDATA'S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

DISEASE OVERVIEW

  • 2.1 INTRODUCTION
    • 2.1.1 Types of Diabetes
    • 2.1.2 Diabetes Complications
    • 2.1.3 Risk Factors Associated with Type 1 and Type 2 Diabetes
    • 2.1.4 Signs and Symptoms
    • 2.1.5 Diabetes Monitoring
    • 2.1.6 Treatment
    • 2.1.7 Drug Delivery Systems

COUNTRY PROFILES

  • 3.1 INTRODUCTION
    • 3.1.1.1 Population
    • 3.1.1.2 GDP Per Capita
    • 3.1.1.3 Units
  • 3.2 GERMANY
  • 3.3 FRANCE
  • 3.4 UNITED KINGDOM
  • 3.5 ITALY
  • 3.6 SPAIN
  • 3.7 BENELUX
  • 3.8 SCANDINAVIA
  • 3.9 AUSTRIA
  • 3.10 SWITZERLAND
  • 3.11 PORTUGAL

CONTINUOUS GLUCOSE MONITORING MARKET

  • 4.1 INTRODUCTION
  • 4.2 MARKET OVERVIEW
  • 4.3 MARKET ANALYSIS AND FORECAST
    • 4.3.1 Total CGM Market
    • 4.3.2 CGM System Market
    • 4.3.3 CGM Sensor Market
    • 4.3.4 Emerging Markets: Non-Invasive CGM
  • 4.4 DRIVERS AND LIMITERS
    • 4.4.1 Market Drivers
    • 4.4.2 Market Limiters
  • 4.5 COMPETITIVE MARKET SHARE ANALYSIS

ABBREVIATIONS

Back to Top